Carterra Launches Sensitive Platform: Ultra™ Advan...
Category : Approval/Launch 6 September 2024Overview Carterra has unveiled its latest platform, Carterra Ultra™, an addition to its LSA...
News
Despite Trial Scare, Travere’s Filspari Gains Full...
Category : Approval/Launch 6 September 2024Despite trial scare, Travere’s Filspari gains full FDA nod in kidney disease showdown with Nov...
UltraDx Receives First Clinical Approval of Single...
Category : Approval/Launch 6 September 2024Overview UltraDx Bio has announced that its flagship product, the UD-X Fully Automated Single-Mol...
Regenxbio Reports Positive Results from Phase I/II...
Category : Clinical Trial Update 5 September 2024Regenxbio reports positive results from phase I/II/III CAMPSIITE trial of RGX-121 to treat patients...
Merck, EyeBio Initiate Phase 2b/3 Trial for Restor...
Category : Clinical Trial Update 5 September 2024Overview Merck, known as MSD outside of the United States and Canada, and EyeBio, a wholly-owned...
Latest Newsletter Post
-
Carterra Launches Sensitive Platfor..
6 September 2024
-
Despite Trial Scare, Travere’s Fils..
6 September 2024
-
UltraDx Receives First Clinical App..
6 September 2024
-
WHO Launches New Online Course for..
5 September 2024
-
Regenxbio Reports Positive Results..
5 September 2024
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-335
Mobile: +91-9990237670
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com